|Podcasts|April 1, 2021

Episode 79: Managing Quarantine Remotely

Uche Iloeje, Vice President medical affairs Mirdametenib at SpringWorks Therapeutics, shares his experience after he became stranded in Nigeria for five months and the valuable leadership lessons he learned.

Uche Iloeje, Vice President medical affairs Mirdametenib at SpringWorks Therapeutics talks about how he had to unexpectedly work remotely from Nigeria during the first few months of the pandemic, and how he and his company dealt with it.

You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.


Related to this article

Pharmaceutical Executive Daily
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.
Pharmaceutical Executive Daily
FDA approves Merck KGaA’s Pimjetmi for tenosynovial giant cell tumor, Parexel’s Stacy Hurt on when patient input should enter the clinical research process, and Ignite Proteomics’ Dr. Brian Corgiat on adjusting for tumor mutations in treatment decisions.